0001209191-18-009177.txt : 20180212
0001209191-18-009177.hdr.sgml : 20180212
20180212161437
ACCESSION NUMBER: 0001209191-18-009177
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180101
FILED AS OF DATE: 20180212
DATE AS OF CHANGE: 20180212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Suesskind Dan S
CENTRAL INDEX KEY: 0001303873
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16174
FILM NUMBER: 18596516
MAIL ADDRESS:
STREET 1: C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.
STREET 2: 5 BASEL STREET, P.O. BOX 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD
CENTRAL INDEX KEY: 0000818686
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 BAZEL ST
STREET 2: P O B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
BUSINESS PHONE: 9729267267
MAIL ADDRESS:
STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
STREET 2: 5 BAZEL ST PO B 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 49131
3/A
1
doc3a.xml
FORM 3/A SUBMISSION
X0206
3/A
2018-01-01
2018-01-02
0
0000818686
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
0001303873
Suesskind Dan S
C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.
5 BASEL STREET
PETACH TIKVA
L3
4951033
ISRAEL
1
0
0
0
Put Option (Obligation to buy)
25.00
2017-04-04
2018-01-19
Ordinary Shares
19700
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
The Form 3 of the Reporting Person originally filed on January 2, 2018 inadvertently omitted the Put option reported herein. Such Put option was beneficially owned by the Reporting Person prior to such Reporting Person's membership on the Issuer's Board of Directors. The Put option expired on January 19, 2018 and such expiration was reported on a Form 4 filed on January 23, 2018. The Reporting Person does not own any other such Put options.
/s/ Dov Bergwerk, as attorney-in-fact for Dan S. Suesskind
2018-02-12